Status:
UNKNOWN
Efficacy and Safety in Pacemaker and Defibrillator Implantation Via Cephalic Versus Axillary Vein Access (CEPHAX)
Lead Sponsor:
Castilla-La Mancha Health Service
Conditions:
Pacemakers
Defibrillators
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial evaluates the efficacy and safety of axillary versus cephalic venous access in the pacemakers and defibrillators implantation. Half of participants will receive the implant via fl...
Eligibility Criteria
Inclusion
- Patients with a endovenous pacemaker or defibrillator indication.
Exclusion
- Pre-existing ipsilateral pacing electrode.
- Previous ipsilateral lymphadenectomy.
- Indication of cardiac resynchronization therapy.
Key Trial Info
Start Date :
October 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2022
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT03860090
Start Date
October 1 2017
End Date
October 1 2022
Last Update
March 1 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital General Universitario de Ciudad Real
Ciudad Real, Spain, 13005